Published in J Immunol Res on July 09, 2015
Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions. BMC Genomics (2015) 0.81
Experimental and Mathematical-Modeling Characterization of Trypanosoma cruzi Epimastigote Motility. PLoS One (2015) 0.80
Giardia alters commensal microbial diversity throughout the murine gut. Infect Immun (2017) 0.77
Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids. Front Immunol (2016) 0.76
Live-attenuated vaccination increases the diversity of pathogen-specific T cell repertoire triggered in chronic infection responses. Ann Transl Med (2016) 0.75
Dendritic Cells: A Double-Edged Sword in Immune Responses during Chagas Disease. Front Microbiol (2016) 0.75
Parasitic Nematode Immunomodulatory Strategies: Recent Advances and Perspectives. Pathogens (2016) 0.75
Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis (2001) 4.13
Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol (2009) 3.13
Population biology of lymphocytes: the flight for survival. Annu Rev Immunol (2000) 2.96
Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med (1991) 2.68
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol (1997) 2.50
A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell (1991) 2.04
A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med (2000) 2.01
CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog (2006) 1.93
Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol (1994) 1.89
Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol (2002) 1.88
Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. Mem Inst Oswaldo Cruz (2004) 1.74
Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat Rev Microbiol (2006) 1.69
Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci (2006) 1.65
The thymus is a common target organ in infectious diseases. PLoS Pathog (2006) 1.63
The evolution of two Trypanosoma cruzi subgroups inferred from rRNA genes can be correlated with the interchange of American mammalian faunas in the Cenozoic and has implications to pathogenicity and host specificity. Mol Biochem Parasitol (1999) 1.58
Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc Natl Acad Sci U S A (1981) 1.54
Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med (1997) 1.54
Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol (2004) 1.49
Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol (1995) 1.46
Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cell Microbiol (2012) 1.45
Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol (2012) 1.45
The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol (2009) 1.39
How do protozoan parasites survive inside macrophages? Parasitol Today (1999) 1.35
Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. J Cell Sci (2000) 1.33
Trypanosoma cruzi: adaptation to its vectors and its hosts. Vet Res (2009) 1.31
Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J Immunol (1991) 1.27
How protozoan parasites evade the immune response. Trends Parasitol (2002) 1.27
Neuroendocrine control of thymus physiology. Endocr Rev (2000) 1.25
Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun (1999) 1.21
Chagas' disease and the autoimmunity hypothesis. Clin Microbiol Rev (1999) 1.18
Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol (2009) 1.17
B-cell biology and development. J Allergy Clin Immunol (2013) 1.16
Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. Proc Natl Acad Sci U S A (1986) 1.14
Interactions between intestinal compounds of triatomines and Trypanosoma cruzi. Trends Parasitol (2010) 1.13
Inhibition of mitogen-induced proliferation of mouse T and B lymphocytes by bloodstream forms of Trypanosoma cruzi. J Immunol (1983) 1.13
Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol Lett (1998) 1.12
Immunosuppression and Chagas disease: a management challenge. PLoS Negl Trop Dis (2013) 1.12
Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J Virol (1995) 1.12
Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion. Microb Pathog (2005) 1.12
Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain. J Biol Chem (1995) 1.11
A hassle a day may keep the pathogens away: The fight-or-flight stress response and the augmentation of immune function. Integr Comp Biol (2009) 1.10
The T-cell receptor repertoire of regulatory T cells. Immunology (2008) 1.09
Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun (2004) 1.08
Experimental Trypanosoma cruzi infection alters the shaping of the central and peripheral T-cell repertoire. Microbes Infect (2003) 1.08
Differential regional immune response in Chagas disease. PLoS Negl Trop Dis (2009) 1.08
The protozoan Trypanosoma cruzi has a family of genes resembling the mucin genes of mammalian cells. J Biol Chem (1995) 1.07
Thymic epithelium in AIDS. An immunohistologic study. Am J Pathol (1986) 1.05
Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts. J Immunol (1998) 1.05
Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun (2007) 1.04
Studies on the thymus in Chagas' disease. I. Changes in the thymic microenvironment in mice acutely infected with Trypanosoma cruzi. Eur J Immunol (1989) 1.04
Polyclonal B lymphocyte activation during Trypanosoma cruzi infection. J Immunol (1980) 1.03
Autoimmune myocarditis induced by Trypanosoma cruzi. Circulation (1985) 1.03
Multigene families in Trypanosoma cruzi and their role in infectivity. Infect Immun (2012) 1.01
Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr Top Microbiol Immunol (2005) 1.01
Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunol (1991) 1.00
Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J Infect Dis (1992) 1.00
Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures. J Biol Chem (2003) 1.00
Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite. Carbohydr Res (2011) 1.00
Modulation of thymocyte subsets during acute and chronic phases of experimental Trypanosoma cruzi infection. Immunology (1992) 1.00
Analysis of macrophage activation in African trypanosomiasis. J Leukoc Biol (2001) 0.99
Alteration of macrophage function by a Trypanosoma cruzi membrane mucin. J Immunol (1997) 0.99
Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol (2006) 0.99
Studies on the thymus in Chagas' disease. II. Thymocyte subset fluctuations in Trypanosoma cruzi-infected mice: relationship to stress. Scand J Immunol (1991) 0.98
Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E). Cell Microbiol (2009) 0.97
Leishmania major surface protease Gp63 interferes with the function of human monocytes and neutrophils in vitro. APMIS (1994) 0.97
Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop (2002) 0.97
B-cell tolerance: mechanisms and implications. Curr Opin Immunol (2010) 0.97
The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog (2011) 0.96
Childhood parasitic infections endemic to the United States. Pediatr Clin North Am (2013) 0.96
Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int Immunol (2002) 0.96
Autoimmunity. Adv Parasitol (2011) 0.96
Glycoinositolphospholipid from Trypanosoma cruzi: structure, biosynthesis and immunobiology. Adv Parasitol (2004) 0.94
Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi. Eur J Cell Biol (2009) 0.93
Trypanosoma cruzi-Induced Host Immune System Dysfunction: A Rationale for Parasite Immunosuppressive Factor(s) Encoding Gene Targeting. J Biomed Biotechnol (2001) 0.93
Chagasic thymic atrophy does not affect negative selection but results in the export of activated CD4+CD8+ T cells in severe forms of human disease. PLoS Negl Trop Dis (2011) 0.92
Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease. Braz J Med Biol Res (2011) 0.92
Plasmodium chabaudi chabaudi (AS): differential cellular responses to infection in resistant and susceptible mice. Exp Parasitol (2005) 0.91
Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. Eur J Immunol (1999) 0.90
Immunoregulation in experimental disseminated histoplasmosis: flow microfluorometry (FMF) studies of the Thy and Lyt phenotypes of T lymphocytes from infected mice. J Immunol (1983) 0.88
The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol (2005) 0.87
Caspase-8 and caspase-9 mediate thymocyte apoptosis in Trypanosoma cruzi acutely infected mice. J Leukoc Biol (2012) 0.87
Thymus invasion and atrophy induced by Paracoccidioides brasiliensis in BALB/c mice. Med Mycol (2003) 0.87
Glycoinositolphospholipids purified from Trypanosoma cruzi stimulate Ig production in vitro. J Immunol (1996) 0.86
Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy. Clin Exp Immunol (2000) 0.86
Quorum sensing contributes to activated IgM-secreting B cell homeostasis. J Immunol (2012) 0.85
Genome evolution in trypanosomatid parasites. Parasitology (2014) 0.85
The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin. Int Immunol (2004) 0.85
TNF-α is involved in the abnormal thymocyte migration during experimental Trypanosoma cruzi infection and favors the export of immature cells. PLoS One (2012) 0.84
Addition of α-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruzi. Glycoconj J (2013) 0.84
Flow microfluorometry analysis of alterations in T-lymphocyte subsets during murine listeriosis. Infect Immun (1984) 0.83
Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity. J Immunol (1987) 0.83
The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits. Mol Biochem Parasitol (2002) 0.80
Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infection. PLoS One (2013) 0.80
Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human chagas disease. PLoS Negl Trop Dis (2014) 0.80
Virulence and pathogenicity associated with diversity of Trypanosoma cruzi stocks and clones derived from Chagas' disease patients. Am J Trop Med Hyg (1996) 0.79
Immune evasion strategies of trypanosomes: a review. J Parasitol (2011) 0.79
Intrathymic effect of acute pathogenic SHIV infection on T-lineage cells in newborn macaques. Microbiol Immunol (2005) 0.78